Joseph L. Dieleman
University of Washington
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Joseph L. Dieleman.
JAMA | 2016
Joseph L. Dieleman; Ranju Baral; Maxwell Birger; Anthony L. Bui; Anne Bulchis; Abigail Chapin; Hannah Hamavid; Cody Horst; Elizabeth K. Johnson; Jonathan Joseph; Rouselle F. Lavado; Liya Lomsadze; Alex Reynolds; Ellen Squires; Madeline Campbell; Brendan DeCenso; Daniel Dicker; Abraham D. Flaxman; Rose Gabert; Tina Highfill; Mohsen Naghavi; Noelle Nightingale; Tara Templin; Martin Tobias; Theo Vos; Christopher J. L. Murray
Importance US health care spending has continued to increase, and now accounts for more than 17% of the US economy. Despite the size and growth of this spending, little is known about how spending on each condition varies by age and across time. Objective To systematically and comprehensively estimate US spending on personal health care and public health, according to condition, age and sex group, and type of care. Design and Setting Government budgets, insurance claims, facility surveys, household surveys, and official US records from 1996 through 2013 were collected and combined. In total, 183 sources of data were used to estimate spending for 155 conditions (including cancer, which was disaggregated into 29 conditions). For each record, spending was extracted, along with the age and sex of the patient, and the type of care. Spending was adjusted to reflect the health condition treated, rather than the primary diagnosis. Exposures Encounter with US health care system. Main Outcomes and Measures National spending estimates stratified by condition, age and sex group, and type of care. Results From 1996 through 2013,
Health Affairs | 2012
Katherine Leach-Kemon; David P. Chou; Matthew T. Schneider; Annette Tardif; Joseph L. Dieleman; Benjamin Pc Brooks; Michael Hanlon; Christopher J L Murray
30.1 trillion of personal health care spending was disaggregated by 155 conditions, age and sex group, and type of care. Among these 155 conditions, diabetes had the highest health care spending in 2013, with an estimated
The Lancet | 2016
Joseph L. Dieleman; Matthew T Schneider; Annie Haakenstad; Lavanya Singh; Nafis Sadat; Maxwell Birger; Alex Reynolds; Tara Templin; Hannah Hamavid; Abigail Chapin; Christopher J. L. Murray
101.4 billion (uncertainty interval [UI],
Health Affairs | 2014
Joseph L. Dieleman; Casey M Graves; Tara Templin; Elizabeth K. Johnson; Ranju Baral; Katherine Leach-Kemon; Annie Haakenstad; Christopher J. L. Murray
96.7 billion-
The Lancet | 2016
Joseph L. Dieleman; Tara Templin; Nafis Sadat; Patrick Reidy; Abigail Chapin; Kyle Foreman; Annie Haakenstad; Timothy G Evans; Christopher J. L. Murray; Christoph Kurowski
106.5 billion) in spending, including 57.6% (UI, 53.8%-62.1%) spent on pharmaceuticals and 23.5% (UI, 21.7%-25.7%) spent on ambulatory care. Ischemic heart disease accounted for the second-highest amount of health care spending in 2013, with estimated spending of
The Lancet | 2015
Jill Olivier; Clarence Tsimpo; Regina Gemignani; Mari Shojo; Harold Coulombe; Frank Dimmock; Minh Cong Nguyen; Harrison Hines; Edward J Mills; Joseph L. Dieleman; Annie Haakenstad; Quentin Wodon
88.1 billion (UI,
JAMA | 2015
Joseph L. Dieleman; Casey M Graves; Elizabeth K. Johnson; Tara Templin; Maxwell Birger; Hannah Hamavid; Michael K. Freeman; Katherine Leach-Kemon; Lavanya Singh; Annie Haakenstad; Christopher J. L. Murray
82.7 billion-
PLOS Medicine | 2014
Marie Ng; Joseph L. Dieleman; Abraham D. Flaxman; Christopher J L Murray; Stephen S Lim
92.9 billion), and low back and neck pain accounted for the third-highest amount, with estimated health care spending of
PLOS ONE | 2014
Joseph L. Dieleman; Tara Templin
87.6 billion (UI,
JAMA | 2017
Joseph L. Dieleman; Ellen Squires; Anthony L. Bui; Madeline Campbell; Abigail Chapin; Hannah Hamavid; Cody Horst; Zhiyin Li; Taylor Matyasz; Alex Reynolds; Nafis Sadat; Matthew T Schneider; Christopher J. L. Murray
67.5 billion-
